Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).

Name: Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).
Published: 2026
License: Public Domain

AlphaMol Science Ltd. (Shanghai) · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

chronic spontaneous urticaria (csu), healthy volunteers, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).

Related documents